Recent pan-cancer analyses have also confirmed that OTUD6B is expressed at relatively higher levels in most tumors than in normal tissues and that high OTUD6B expression is significantly associated with a poor prognosis in patients with lung adenocarcinoma, breast invasive carcinoma, hepatocellular carcinoma, and thyroid cancer [88]. Here, OTUD6B is linked to thyroid cancer.